FOXBOROUGH, Mass.--(BUSINESS WIRE)--Cyberkinetics Neurotechnology Systems, Inc. (OTCBB:CYKN; “Cyberkinetics”; "the Company") announced today that it has entered into definitive agreements to privately sell $10.0 million of newly issued shares of common stock and warrants to purchase additional shares of common stock to institutional and accredited investors. The Company expects to close the transaction subject to customary closing conditions.
